Molecules/DOSTARLIMAB

DOSTARLIMAB

Molecular Identity

AntibodyApprovedFirst approved 2021

Mechanism of action: Programmed cell death protein 1 antagonist

Molecular Formula

0.00

Molecular Weight

g/mol

DOSTARLIMABDOSTARLIMAB GXLYDOSTARLIMAB-GXLYGSK-4057190GSK4057190JemperliTSR 042TSR-042TSR042WBP-285WBP285

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to DOSTARLIMAB

Loading drug network...